Alfonso Quintas Cardama insider trades

Open-market stock purchases and sales by Alfonso Quintas Cardama, Chief Medical Officer at Foghorn Therapeutics Inc, from SEC Form 4 filings since Apr 11, 2019.

Recent trades

DateStockTradeValue
Jan 30, 2026FHTX Foghorn Therapeutics IncBought (not open market)$1.7M

Companies traded

  • FHTX Foghorn Therapeutics Inc: other filings, last Jan 30, 2026
  • TCRR Tcr2 Therapeutics Inc: 8 sales, last Jun 1, 2023

Get free alerts when Alfonso Quintas Cardama files a new trade →